연구활동

임상연구 지원사업

재단법인의 발전을 위하여 후원사에서 지급하는 산학협동 연구비를 재원으로 심장혈관질환 분야의 연구 의욕을 고취시키기 의하여 연구계획서를 제출한 과제를 대상으로 연구자를 선정하여 연구비를 지원하며, 또한 심장혈관질환 관련 임상자료를 취합하여 새로운 치료법을 모색하고자 프로토콜을 작성 연구자를 선정하여 연구비를 지원하고 있습니다.

Research Activity

  • Intravascular Ultrasound Study to Evaluate Cardiac Allograft Vasculopathy in Heart Transplant Recipients
  • Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Anticoagulant versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
  • Asan Medical Center Myocardial Infarction registry (AMC-MI registry)
  • Perioperative antiplatelet therapy in patients with drug-eluting stent undergoing noncardiac surgery
  • BVS Implantation in Patients with Variant Angina and MODerate coronary artery disease: Pilot study
  • IRIS CTO; a multicenter, prospective, real world observational study for Chronic Total Occlusion
  • An open-label, randomized, controlled, multicenter study comparing two treatment strategies of Edoxaban alone and Edoxaban with antiplatelet agent in patients with atrial fibrillation and chronic stable coronary artery disease
  • Early Left Atrial Venting Versus Conventional Treatment For Left VEntricular Decompression During Venoarterial ExtraCorporeal Membrane Oxygenation Support
  • Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
  • Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of BioFreedom stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice ; A Multicenter, Prospective Observational Study
  • Evaluation of effectiveness and safety of Drug-Eluting Balloon in Routine Clinical Practice; A multicenter prospective observational cohort study (IRIS-DEB)
  • Evaluation of Effectiveness and Safety of DESyne X2R in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • A Multicenter, prospective cohort to evaluate the natural history of FFR guided Percutaneous Coronary Intervention (IRIS FFR Registry)
  • A Multicenter, prospective cohort to evaluate the effect of FFR guided Percutaneous Coronary Intervention in coronary tandem lesions (IRIS FFR Tandem Registry)
  • Prognosis of Coronary Stenosis based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
  • Prognosis of Coronary Stenosis based on Grayscale Intravascular Ultrasound; A Multicenter, Prospective Observational Study
  • IRIS MAIN ; a global, multicenter, prospective, real world observational study for left main disease treatment
  • Evaluation of Effectiveness and Safety of Resolute Onyx in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Synergy Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of XIENCE XPEDITION in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Optical Coherence Tomography versus IntraVascular UltraSound Guided Percutaneous Coronary Intervention Trial
  • IRIS MAIN ; a global, multicenter, prospective, real world observational study for left main disease treatment
  • Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PRE-COMBAT Trial
  • The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque
  • Prognosis of Coronary Stenosis based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
  • Debulking with Rotational atherectomy versus Balloon Angioplasty In Patients with In-stent Restenosis
  • Comparison of Tailored Antiplatelet Therapy With Early Intensified and Late Deescalated Strategy versus Standard Dual Antiplatelet Therapy in Patients Undergoing High-Risk Complex Percutaneous Coronary Intervention
  • TransPacific TAVR Registry(Multinational Multicenter Prospective Registry)
  • Implantable Cardioverter Defibrillator versus Optimal Medical Therapy In Patients with Variant Angina Manifesting as Aborted Sudden Cardiac Death (VARIANT-ICD trial)
  • The BEST TRIAL Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease: Phase IV: Multicenter
  • Optimal Duration of Clopidogrel Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS-LATE trial)
  • Optimal Duration of Clopidogrel Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS-LATE trial)
  • A Randomized, Double-blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in Deferred Coronary Disease
  • HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging versus Quantitative Coronary Angiography guidance: HOWTO-BRS trial
  • Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of DESyne in Routine Clinical Practice ; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of PROMUS Element in Routine Clinical Practice; A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of effectiveness and safety of Resolute Integrity DES in Routine Clinical Practice; A multicenter prospective observational cohort study
  • Evaluation of Effectiveness and Safety of NOBORI stent in Routine Clinical Practice;A multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of Orsiro in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study
  • Evaluation of Effectiveness and Safety of XIENCE PRIME in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of Ultimaster stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-VI: Everolimus-eluting (Xience-Prime) vs. Zotarolimus-Eluting (Resolute-Integrity) Stents
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)
  • Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
  • Device Closure versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients with High-Risk Patent Foramen Ovale : DEFENSE-PFO trial
  • Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention: POST-PCI trial
  • Effectiveness of Clopidogrel Resinate(PRegrel? in Patients Undergoing Percutaneous Coronary Intervention compared with ClopiDogrEl Bisulfate(Plavix?
  • Transcatheter Aortic Valve Replacement for Pure Severe Aortic Regurgitation Pilot study
  • Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis
  • Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients with Acute Coronary Syndromes; Pharmacodynamics and Pharmacokinetics Study (The OPTIMA Trial)
  • A randomized, open-label, parallel group, multicenter phase IV study to assess safety and efficacy of Ticagrelor versus Clopidogrel in Asian/KOREAn patients with acute coronary syndromes intended for invasive management: TICAKOREA Trial